Ana Pereira1, Maria Luisa Garmendia2, Ricardo Uauy1,3,4, Paulina Neira5, Sandra Lopez-Arana6, Serghei Malkov7, John Shepherd7. 1. Institute of Nutrition and Food Technology, University of Chile, Av. El Líbano 5524, Macúl, Santiago, 7830490, Chile. 2. Institute of Nutrition and Food Technology, University of Chile, Av. El Líbano 5524, Macúl, Santiago, 7830490, Chile. mgarmendia@inta.uchile.cl. 3. Pediatrics Division, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. 4. London School of Hygiene and Tropical Medicine, London, UK. 5. Imágenes de la mama, Servicio de Radiología, Clínica Las Condes, Santiago, Chile. 6. Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. 7. Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Abstract
PURPOSE: High mammographic breast density (BD) is a strong risk factor of breast cancer; however, little is known in women under 40 years of age. Recently, dual-energy X-ray Absorptiometry (DXA) has been developed as a low-dose method to measure BD in young populations. Thus, our aims were to describe BD in relation to risk factors in Chilean women under 40 years old and to explore the equivalence of DXA to mammography for the measurement of BD. METHODS: We selected 192 premenopausal Chilean female participants of the DERCAM study for whom we have anthropometric, sociodemographic, and gyneco-obstetric data. The subjects received both digital mammograms (Hologic) and breast DXA scans (GE iDXA). Mammographic BD was estimated using a fully automated commercial method (VOLPARA®) and BI-RADS. Breast DXA scans were performed using a standardized protocol and the % fibroglandular volume (%FGV) was estimated considering a two-compartment model of adipose and fibroglandular tissue. RESULTS: The mean age was 37 years (SD = 6.5) and 31.6% of the subjects were obese. The median %FGV and absolute FGV (AFGV) measured by DXA were 9% and 198.1 cm3 and for VOLPARA®, 8.6% and 58.0 cm3, respectively. The precision for %FGV after reposition was 2.8%. The correlation coefficients for %FGV, AFGV, and breast volume between DXA and mammography were over 0.7. Age and body mass index (BMI) were inversely associated with %FGV, and BMI was positively related to AFGV as estimated with DXA or mammography. We did not observe an association with gyneco-obstetric characteristics, education, and %FGV and AFGV; smoking was only associated with AFGV as measured by VOLPARA®. CONCLUSIONS: DXA is an alternative method to measure volumetric BD; thus, it could be used to continuously monitor BD in adult women in follow-up studies or to assess BD in young women.
PURPOSE: High mammographic breast density (BD) is a strong risk factor of breast cancer; however, little is known in women under 40 years of age. Recently, dual-energy X-ray Absorptiometry (DXA) has been developed as a low-dose method to measure BD in young populations. Thus, our aims were to describe BD in relation to risk factors in Chilean women under 40 years old and to explore the equivalence of DXA to mammography for the measurement of BD. METHODS: We selected 192 premenopausal Chilean female participants of the DERCAM study for whom we have anthropometric, sociodemographic, and gyneco-obstetric data. The subjects received both digital mammograms (Hologic) and breast DXA scans (GE iDXA). Mammographic BD was estimated using a fully automated commercial method (VOLPARA®) and BI-RADS. Breast DXA scans were performed using a standardized protocol and the % fibroglandular volume (%FGV) was estimated considering a two-compartment model of adipose and fibroglandular tissue. RESULTS: The mean age was 37 years (SD = 6.5) and 31.6% of the subjects were obese. The median %FGV and absolute FGV (AFGV) measured by DXA were 9% and 198.1 cm3 and for VOLPARA®, 8.6% and 58.0 cm3, respectively. The precision for %FGV after reposition was 2.8%. The correlation coefficients for %FGV, AFGV, and breast volume between DXA and mammography were over 0.7. Age and body mass index (BMI) were inversely associated with %FGV, and BMI was positively related to AFGV as estimated with DXA or mammography. We did not observe an association with gyneco-obstetric characteristics, education, and %FGV and AFGV; smoking was only associated with AFGV as measured by VOLPARA®. CONCLUSIONS: DXA is an alternative method to measure volumetric BD; thus, it could be used to continuously monitor BD in adult women in follow-up studies or to assess BD in young women.
Entities:
Keywords:
Breast cancer; Breast density; Dual-energy X-ray absorptiometry; Prememopausal women
Authors: Jennifer E Kay; Bethsaida Cardona; Ruthann A Rudel; Laura N Vandenberg; Ana M Soto; Sofie Christiansen; Linda S Birnbaum; Suzanne E Fenton Journal: Curr Environ Health Rep Date: 2022-08-19
Authors: Constanza Lesser; Verónica Mericq; Marcela Reyes; María Luisa Garmendia; John A Shepherd; Karin B Michels; Camila Corvalán; Ana Pereira Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-07-01 Impact factor: 4.090
Authors: Ana López; María Luisa Garmendia; John Shepherd; Karin Michels; Camila Corvalán; Ana Pereira Journal: Sci Rep Date: 2020-04-20 Impact factor: 4.379